• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    18.98 Up 0.42(2.26%) 4:00PM EST
    |After Hours : 18.98 0.00 (0.00%) 4:25PM EST
    Prev Close:18.56
    Open:18.85
    Bid:18.45 x 200
    Ask:24.19 x 900
    1y Target Est:34.13
    Beta:1.68307
    Earnings Date:Feb 23 - Feb 29 (Est.)
    Day's Range:18.53 - 20.80
    52wk Range:17.76 - 116.75
    Volume:995,849
    Avg Vol (3m):2,255,070
    Market Cap:727.32M
    P/E (ttm):N/A
    EPS (ttm):-8.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSUp 2.26%727.32M
    IMMUDown 4.35%187.59M
    THLDDown 0.60%20.03M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-9.03
    Quarterly EPS Est (Dec-15) :-2.44
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback